The Next Phase: Exploring Innovation in Clinical Trials

When you're halfway around the world and you need to make a purchase, it's as easy as pulling a plastic card out of your wallet and swiping. Why can't we have the same simplicity with our healthcare data?   The answer is complex, according to Arlen Meyers, President and CEO of the Society of Physician Entrepreneurs. A medical doctor and a startup consultant, Dr. Meyers, discusses all the ways we can work toward ethical data exchange and improve on what he calls our “sick care system.”   Join us as we discuss: What interoperability for healthcare and clinical trial data means Barriers to interoperability Why physicians and business people must work together on data exchange How owning their data can empower patients in clinical trials Why technology is essential for data exchange between physicians, patients, and healthcare organizations

You wouldn't take a drug if you didn't know if it was going to help you.  It might surprise you to hear millions of people do this every day. Not because they don't care or don't want to know, but because they live in a system that wasn't built for them.   This is the reality for underrepresented communities and racial and ethnic minorities who have been all-but-locked-out of the clinical trial process.   Tiffany Whitlow, Co-Founder & Chief Development Officer at Acclinate, shares her insights about the depth of inequity in the clinical trials system and how we can fix it.   Join us as we discuss: How Tiffany co-founded a company made to bring DEI back into clinical trials The surprising statistics surrounding inequity in healthcare How Acclinate is changing the system to bring clinical trials to those who need them most What pharmaceutical sponsors and research sites need to do to increase clinical trial equity 

Capping off season 2 of “The Next Phase,” this episode looks back at the insights and key learnings gleaned from conversations with industry experts as they've unpacked the innovations driving clinical research in a post-pandemic economy. Blake is joined by Florence Healthcare's co-founder and CEO Ryan Jones to discuss what's happening in clinical research today and the innovations Ryan anticipates will have the biggest impact on the industry. 

This episode dives into epidemiology and real-world evidence, as host Blake Adams and Paul Petraro, Global Head of Real World Evidence, Data Analytics, Value Evidence and Outcomes for Boehringer Ingelheim explore the evolution of real-world data, its use cases, and the need for trust and transparency when leveraging information across the clinical research industry.

As the world becomes increasingly digital, clinical trials using real-world evidence are armed with more data than ever before. In this episode, Blake speaks with Tracey Robertson, Global Process Lead for Boehringer Ingelheim, about how researchers can take that data and turn it into findings that support actionable outcomes and leverage technology that makes trials effective, scalable, and impactful. 

In this episode, Blake speaks with Michelle Shogren, Senior Director of Innovation at Bayer, about how incorporating the patient experience in decentralized models breathes innovation into clinical trials. 

In this episode, host Blake Adams discusses investment trends in the clinical research industry with Joe Munda, Senior Vice President of First Analysis. 

Join host Blake Adams for a conversation with Amir Lahav, Head of Digital R&D, Mitsubishi Tanabe Pharma Holdings America, about the innovative ways companies can approach decentralized trials in a post-pandemic world.

In this episode, brought to you by the Florence Diversity and Inclusion Committee, host Blake Adams and Leslie Byatt, clinical research manager for NMCCA and UNMCCC, discuss the importance of diversity – for both people and technology – across research initiatives.

In this episode, host Blake Adams and Sholeh Ehdaivand, founder, president and CEO of LMK Clinical Research Consulting, discuss Trial Master Files (TMF) and their pivotal role in the future of real-time collaboration between clinical research sites and sponsors.   

Join host Blake Adams and Maxis Medical's Executive Vice President Suji Shetty to discover how technology is streamlining clinical operations processes.

 Join host Blake Adams and ACRP Workforce Innovation Officer Beth Harper as they explore the evolving CRA/CTA landscape, and how roles are shifting as technology continues to play a stronger role in clinical operations.

Join Florence executives in unpacking its Annual State of the Industry Report for 2021. This year's report features insights from over 230 clinical operations leaders and delves into how they're making strategic investments in technology after one of the most disruptive years in clinical operations history.

Join host Blake Adams and Spesana's Founder and CEO Carla Balch in a discussion about the trends and technologies improving collaboration in molecular diagnostics.